ebook img

Neurology 2001: Vol 57 Index PDF

35 Pages·2001·15.4 MB·English
by  
Save to my drive
Quick download
Download
Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.

Preview Neurology 2001: Vol 57 Index

Subject index to volume 57 A cholesterol and Alzheimer’s disease: is there a link? (Simons et al), 2001;57:1089 Abortion cholesterol and neuropathological markers of AD: a population-based risk of epilepsy in offspring of affected women: association with autopsy study (Launer et al), 2001;57:1447 maternal spontaneous abortion (Schupf and Ottman), 2001;57:1642 cognitive tests that best discriminate between presymptomatic AD and Acetaminophen those who remain nondemented (Tierney) (Letter); (Chen et al) prophylactic antipyretic treatment with acetaminophen in acute (Reply), 2001;57:163 ischemic stroke: a pilot study (Koennecke and Leistner), 2001;57 controlled trial of N-acetylcysteine for patients with probable 2301 Alzheimer’s disease (Adair et al), 2001;57:1515 Acetazolamide cystatin C polymorphism is not associated with early onset Alzheimer’s acetazolamide for the treatment of migraine with aura in CADASIL disease (Roks et al), 2001;57:366 (Forteza et al), 2001;57:2144 decrease of N-acetylaspartate in the MTL correlates with cognitive Acetylaspartate decline of AD patients (Jessen et al), 2001;57:930 decrease of N-acetylaspartate in the MTL correlates with cognitive decline of AD patients (Jessen et al), 2001;57:930 dementia with Lewy bodies and AD are not associated with occipital lobe atrophy on MRI (Middelkoop et al), 2001;57:2117 Acetylcysteine differing patterns of temporal atrophy in Alzheimer’s disease and controlled trial of N-acetylcysteine for patients with probable semantic dementia (Galton et al), 2001;57:216 Alzheimer’s disease (Adair et al), 2001;57:1515 dissociation of regional activation in mild AD during visual encoding: a Acid maltase deficiency juvenile and adult-onset acid maltase deficiency in France: genotype functional MRI study (Kato et al), 2001;57:812 genome-wide linkage disequilibrium mapping of late-onset Alzheimer’s phenotype correlation (Ausems et al) (Letter); (Laforét et al (Reply), 2001;57:1938 disease in Finland (Hiltunen et al), 2001;57:1663 sleep-disordered breathing and respiratory failure in acid maltase head circumference and incident Alzheimer’s disease: modification by deficiency (Mellies et al), 2001;57:1290 apolipoprotein E (Graves et al), 2001;57:1453 Acute coronary syndromes high-dose estradiol improves cognition for women with AD: results of a from bench to bedside: GP IIb-IIla inhibitors (Fintel) (Sept, suppl 2 randomized study (Asthana et al), 2001;57:605 2001;57:S12 impaired affective prosody in AD: relationship to aphasic deficits and Adrenomyeloneuropathy emotional behaviors (Testa et al), 2001;57:1474 ABCD1 translation-initiator mutation demonstrates genotype incidence of Alzheimer’s disease in a rural community in India: the phenotype correlation for AMN (O'Neill et al), 2001;57:1956 Indo-US study (Chandra et al), 2001;57:985 African Americans increased CSF cortisol in AD is a function of APOE genotype (Sass et apolipoprotein E and age at onset of Alzheimer’s disease in African al) (Letter); (Wilkinson and Peskind) (Reply), 2001;57:1522 American patients (Goldstein et al), 2001;57:1923 influence of leisure activity on the incidence of Alzheimer’s disease Aging. See a/so Elderly people (Scarmeas et al), 2001;57:2236 effects of estrogen replacement therapy on human brain aging lack of an association between cystatin C gene polymorphisms in vivo 'H MRS study (Robertson et al), 2001;57:2114 Japanese patients with Alzheimer’s disease (Maruyama et al), evidence for cortical “disconnection” as a mechanism of age-related 2001;57:337 cognitive decline (O’Sullivan et al), 2001;57:632 measuring Alzheimer’s disease progression with transition Agnosia probabilities: estimates from CERAD (Neumann et al), 2001;57:957 agnosia for familiar faces and odors in a patient with right tempora models of progression in AD: predicting disability and costs lobe dysfunction (Mendez and Ghajarnia), 2001;57:519 (Mendiondo et al) (Editorial), 2001;57:943 AIDS. See Human immunodeficiency virus MRI predictors of cognition in subcortical ischemic vascular disease Albuterol and Alzheimer’s disease (Mungas et al), 2001;57:2229 randomized, double-blind, placebo-controlled trial of albuterol in novel presenilin 2 gene mutation (D439A) in a patient with early onset facioscapulohumeral dystrophy (Kissel et al), 2001;57:1434 Alzheimer’s disease (Lle6 et al), 2001;57:1926 Alcohol intake l-year, placebo-controlled preservation of function survival study of mapping callosal morphology and cognitive correlates: effects of heavy donepezil in AD patients (Mohs et al), 2001;57:481 prenatal alcohol exposure (Sowell et al), 2001;57:235 l-year, randomized, placebo-controlled study of donepezil in patients Allodynia with mild to moderate AD (Winblad et al), 2001;57:489 experimental brush-evoked allodynia activates posterior parietal cortex psychosis of Alzheimer’s disease is associated with elevated muscarinic (Witting et al), 2001;57:1817 M, binding in the cortex (Lai et al), 2001;57:805 Aimotriptan quantification of tissue damage in AD using diffusion tensor and dose finding, placebo-controlled study of oral almotriptan in the acute magnetization transfer MRI (Bozzali et al), 2001;57:1135 treatment of migraine (Dahléf et al), 2001;57:1811 rates of global and regional cerebral atrophy in AD and frontotemporal Alternative therapies dementia (Chan et al), 2001;57:1756 use of alternative therapies by patients with Parkinson’s disease reduced levels of amyloid B-peptide antibody in Alzheimer disease (Du (Rajendran et al), 2001;57:790 et al), 2001;57:801 hoi r’s di screening for PS1 mutations in a referral-based series of AD cases: 21 accuracy of clinical criteria for AD in the Honolulu-Asia Aging Study novel mutations (Rogaeva et al), 2001;57:621 population-based study (Petrovitch et al), 2001;57:226 semantic dementia versus Alzheimer’s disease: a matter of semantics? amyloid precursor protein in platelets: a peripheral marker for the (Morris and Balota) (Editorial), 2001;57:173 diagnosis of sporadic AD (Padovani et al), 2001;57:2243 specificity of the fivefold increase AD in mothers of adults with Down apolipoprotein E and age at onset of Alzheimer’s disease in African syndrome (Schupf et al), 2001;57:979 American patients (Goldstein et al), 2001;57:1923 24-week, randomized, double-blind study of donepezil in moderate to apolipoprotein E e4 and the pattern of regional brain atrophy in severe Alzheimer’s disease (Feldman et al), 2001;57:613 Alzheimer’s disease (Hashimoto et al), 2001;57:1461 vitamin B,, and folate in relation to the development of Alzheimer’s assessment of health economics in Alzheimer’s disease (AHEAD) disease (Riedez and Fricke) (Letter); (Wang et al) (Reply), 2001;57: galantamine treatment in Canada (Getsios et al), 2001;57:972 1743 assessment of health economics in Alzheimer’s disease (AHEAD) based Amoxicillin on need for full-time care (Caro et al), 2001;57:964 amoxicillin-induced aseptic meningitis (Wittmann and Wooten), 2001; beyond the hippocampus: MRI volumetry confirms widespread limbic 57:1734 atrophy in AD (Callen et al), 2001;57:1669 Amphetamine blood HO-1 mRNA in AD and MCI (Schipper et al), 2001;57:2142 d-amphetamine does not improve outcome of somatosensory training brain metabolite concentration and dementia severity in Alzheimer’s (Knecht et al), 2001;57:2248 disease: a 'H MRS study (Huang et al), 2001;57:626 Amyloid cerebrospinal fluid production rate is reduced in dementia of the amyloid precursor protein in platelets: a peripheral marker for the Alzheimer’s type (Silverberg et al), 2001;57:1763 diagnosis of sporadic AD (Padovani et al), 2001;57:2243 July 10 issue, pp 1-166; July 24 issue, pp 167-372; August 14 issue, pp 373-568; August 28 issue, pp 569-748; September 11 issue, pp 749-940; September, Supplement 2, pp S1-S86; September 25 issue, pp 941-1148; October 9 issue, pp 1149-1354; October 23 issue, pp 1355-1526; November 13 issue, pp 1527-1744; November 27 issue, pp 1745-1942; November, Supplement 3, pp S1-S62; December 11 issue, pp 1943-2154; December, Supplement 4, pp S1-S73; December 26 issue, pp 2155-2362; December, Supplement 5, pp S1-S53 December (2 of 2) 2001 NEUROLOGY 57 2327 production of IL-6 by human myoblasts stimulated with AB: relevance Antioxidants in the pathogenesis of IBM (Baron et al), 2001;57:1561 intakes of carotenoids, vitamin C, and vitamin E and MS risk among recurrent subarachnoid hemorrhage associated with a new two large cohorts of women (Zhang et al), 2001;57:75 transthyretin variant (Gly53Glu) (Ellie et al), 2001;57:135 Antiretroviral agents Amyotrophic lateral sclerosis ALS-like syndrome with new HIV infection and complete response to ALS defeats gabapentin: reflections on another failed treatment antiretroviral therapy (MacGowan et al), 2001;57:1094 (Brigell and Taylor) (Letter); (Rowland and McDermott) (Reply), CSF antiretroviral drug penetrance and the treatment of HIV- 2001;57:1524 associated psychomotor slowing (Sacktor et al), 2001;57:542 ALS-like syndrome with new HIV infection and complete response to Anti-titin antibodies antiretroviral therapy (MacGowan et al), 2001;57:1094 linkage of HLA to myasthenia gravis and genetic heterogeneity clinical implications of the genetics of ALS and other motor neuron depending on anti-titin antibodies (Giraud et al), 2001;57:1555 diseases (Orrell and Figlewicz) (Views & Reviews), 2001;57:9 Aphasia cognitive impairment in sporadic ALS: a pathologic continuum aphasia breaks the news (McGuire) (Nisus), 2001;57:1348 underlying a multisystem disorder (Wilson et al), 2001;57:651 catastrophic reaction in acute stroke: a reflex behavior in aphasic current management of ALS: comparison of the ALS CARE Database patients (Carota et al), 2001;57:1902 and the AAN Practice Parameter (Bradley et al), 2001;57:500 impaired affective prosody in AD: relationship to aphasic deficits and does viral disease underlie ALS?: lessons from the AIDS pandemic emotional behaviors (Testa et al), 2001;57:1474 (Jubelt and Berger) (Editorial), 2001;57:945 syndrome of acquired aphasia with convulsive disorder in children effec: of neurophilin ligands on motor units in mice with SOD1 ALS (Landau and Kleffner) (Dec, suppl 4), 2001;57:S29 mutations (Shefner et al), 2001;57:1857 Apolipoprotein E immune reactivity in a mouse model of familial ALS correlates with APOE genotype is a major predictor of long-term progression of disease progression (Alexianu et al), 2001;57:1282 disability in MS (Becker) (Letter); (Chapman et al) (Reply), 2001; marked increase in cyclooxygenase-2 in ALS spinal cord: implications 57-2148 for therapy (Yasojima et al), 2001;57:952 apolipoprotein E and age at onset of Alzheimer’s disease in African noninvasive ventilation allows gastrostomy tube placement in patients American patients (Goldstein et al), 2001;57:1923 with advanced ALS (Rowin and Meriggioli) (Letter); (Rio and apolipoprotein E e4 and the pattern of regional brain atrophy in Leigh) (Letter); (Boitano et al) (Reply), 2001;57:1351 Alzheimer’s disease (Hashimoto et al), 2001;57:1461 postural change of forced vital capacity predicts some respiratory apolipoprotein E e4 is associated with rapid progression of multiple symptoms in ALS (Varrato et al), 2001;57:357 sclerosis (Fazekas et al), 2001;57:853 prognostic value of decremental responses to repetitive nerve apolipoprotein E genotype, coagulation, and survival following acute stimulation in ALS patients (Wang et al), 2001;57:897 stroke (Weir et al), 2001;57:1097 prospective study of quality of life in ALS patients treated with effect of apolipoprotein E genotype on hippocampal volume loss in noninvasive ventilation (Lyall et al), 2001;57:153 aging healthy women (Cohen et al), 2001;57:2223 quality of life in ALS is maintained as physical function declines effects of APOE genotype on age at onset and progression of (Maillot et al) (Letter); (Simmons et al) (Repiy), 2001;57:1939 neurodegenerative diseases (Chapman et al), 2001;57:1482 respiratory function vs sleep-disordered breathing as predictors of gender difference in the association between APOE genotype and age- QOL in ALS (Bourke et al), 2001;57:2040 related cognitive decline (Mortensen and Hogh), 2001;57:89 reversible ALS-like disorder in HIV infection (Moulignier et al), 2001; head circumference and incident Alzheimer’s disease: modification by 57:995 apolipoprotein E (Graves et al), 2001;57:1453 volumetric analysis reveals corticospinal tract degeneration and increased CSF cortisol in AD is a function of APOE genotype (Sass et extramotor involvement in ALS (Ellis et al), 2001;57:1571 al) (Letter); (Wilkinson and Peskind) (Reply), 2001;57:1522 Amyotrophy memory complaints and APOE-e4 accelerate cognitive decline in clinical characteristics of a family with chromosome 17-linked cognitively normal elderly (Dik et al), 2001;57:2217 disinhibition-dementia-parkinsonism-amyotrophy complex (Lyr.ch Apoptosis et al) (Nov, suppl 3), 2001;57:S39 coenzyme Q,, reverses pathological phenotype and reduces apoptosis craniofacial and cutaneous findings expand the phenotype of in familial CoQ,, deficiency (Di Giovanni et al), 2001;57:515 hereditary neuralgic amyotrophy (Jeannet et al), 2001;57:1963 Apraxia Aneurysms neural and cognitive bases of upper limb apraxia in corticobasal small cerebral aneurysms presenting with symptoms other than degeneration (Peigneux et al), 2001;57:1259 rupture (Friedman et al), 2001;57:1212 prolonged orbicularis oculi activity: a major factor in apraxia of lid Angelman syndrome opening (Tozlovanu et al), 2001;57:1013 high-dose ethosuximide for epilepsy in Angelman syndrome: Arterial dissection implication of GABA, receptor subunit (Sugiura et al), 2001;57: arterial dissection and stroke in children (Fullerton et al) (Views & 1518 Reviews), 2001;57:1155 Angiography. See also Magnetic resonance angiography Arteriovenous fistulas clinical carotid endarterectomy decision-making: noninvasive vascular natural history of an incidentally discovered spinal dural imaging versus angiography (Young and Humphrey) (Letter); arteriovenous fistula (Houdart et al), 2001;57:742 (Johnston and Goldstein) (Reply), 2001;57:2324 Asperger’s syndrome low rate of complications of cerebral angiography in routine clinical Henry Cavendish: an early case of Asperger’s syndrome? (Sacks), 2001; practice (Johnston et al), 2001;57:2012 57:1347 Anoxic-ischemic encephalopathy Asphyxia MRI identification of early white matter injury in anoxic-ischemic 'H-MR spectroscopy is sensitive to subtle effects of perinatal asphyxia encephalopathy (Korn-Lubetzki et al) (Letter); (Chalela et al) (Maneru et al), 2001;57:1115 (Reply), 2001;57:745 Aspirin ANTI gene inhibition of thrombus formation by low-dose acetylsalicylic acid, ANT1, Twinkle, POLG, TP: new genes open our eyes to dipyridamole, and their combination in a model of platelet-vessel ophthalmoplegia (Hirano and DiMauro) (Editorial), 2001;57:2163 wall interaction (Miiller) (Sept, supp! 2), 2001;57:S8 novel missense adenine nucleotide translocator-] gene mutation in a vascular biology of thrombosis: platelet-vessel wall interactions and Greek adPEO family (Napoli et al), 2001;57:2295 aspirin effects (Catella-Lawson) (Sept, supp! 2), 2001;57:S5 Anti-B-amyloid antibodies Astrocytes reduced levels of amyloid 8-peptide antibody in Alzheimer disease (Du differing effects of IFNB vs IFNg in MS: gene expression in cultured et al), 2001;57:801 astrocytes (Satoh and Kuroda), 2001;57:681 Anticoagulation Asystole oral anticoagulation for cerebral ischemia of arterial origin: high initial asystole induced by edrophonium following beta blockade (Okun et al), bleeding risk (Torn et al), 2001;57:1993 2001;57:739 Anti-Gal-C antibodies Ataxia. See also Cerebellar ataxia; Spinocerebellar ataxia anti-Gal-C antibodies in GBS subsequent to mycoplasma infection: acute sensory ataxic neuropathy associated with monospecific anti- evidence of molecular mimicry (Kusunoki et al), 2001;57:736 GD1b IgG antibody (Pan et al), 2001;57:1316 Anti-ganglioside antibodies adult-onset autosomal recessive ataxia with thalamic lesions in a anti-ganglioside antibodies in polyneuropathy associated with Finnish family (Rantamaki et al), 2001;57:1043 monoclonal gammopathy (Eurelings et al), 2001;57:1909 autosomal dominant disorder with episodic ataxia, vertigo, and Anti-GD1b antibody tinnitus (Steckley et al), 2001;57:1499 acute sensory ataxic neuropathy associated with monospecific anti- fatal infantile leukodystrophy: a severe variant of CACH/VWM GD1b IgG antibody (Pan et al), 2001;57:1316 syndrome, allelic to chromosome 3q27 (Francalanci et al), 2001;57: Anti-Hu antibodies 265 systemic lupus erythematosus with anti-Hu antibodies and SCA8 repeat expansions in ataxia: a controversial association (Sobrido polyradiculoneuropathy (Carpentier et al), 2001;57:558 et al), 2001;57:1310 2328 NEUROLOGY 57 December (2 of 2) 2001 serum transferrin receptor levels in Friedreich’s and other Brain Tumors: An Encyclopedic Approach, edited by Kaye and Laws Jr degenerative ataxias (Scarano et al), 2001;57:159 (Abrey), 2001;57:2152 Atrial natriuretic peptide gene The Dying of Enoch Wallace: Life, Death, and the Changing Brain, atrial natriuretic peptide gene G664A polymorphism and the risk of Black (Murphy Jr), 2001;57:568 ischemic cerebrovascular disease (Hassan et al), 2001;57:1726 Early Diagnosis and Interventional Therapy in Cerebral Palsy, edited Attention by Scherzer (Russman), 2001;57:1526 language and spatial attention can lateralize to the same hemisphere Epilepsy in Clinical Practice: A Case Study Approach, edited by Wilner in healthy humans (Fléel et al), 2001;57:1018 (Bergen), 2001;57:748 neural correlates of attention and working memory deficits in HIV Fronte-Subcortical Circuits in Psychiatric and Neurologic Disorders, patients (Chang et al), 2001;57:1001 edited by Lichter and Cummings (Fudge), 2001;57:568 Attentional blink GABA in the Nervous System: The View at Fifty Years, edited by increased attentional blink after focal cerebr al lesions (Rizzo et al Martin and Olsen (Kellogg), 2001;57:1353 2001;57:795 Half a Brain is Enough: The Story of Nico, edited by Battro (Janzen), Attention-deficit/hyperactivity disorder 2001;57:2152 oculomotor abnormalities in attention deficit hyperactivity disorder Harrison’s Principles of Internal Medicine, 15th ed., edited by preliminary study (Mostofsky et al), 2001;57:423 Braunwald et al (Gelb), 2001;57:1941 Autistic disorder Magnetic Resonance Spectroscopy in Multiple Sclerosis, edited by autism in tuberous sclerosis complex is related to both cortical and Filippi et al (Levin), 2001;57:1353 subcortical dysfunction (Asano et al), 2001;57:1269 Muscle Pain: Understanding Its Nature, Diagnosis and Treatment, postmortem brain abnormalities or the glutamate neurotransmitte1 Mense et al (Fields), 2001;57:372 system in autism (Purcell et al), 2001;57:1618 The Neurobiology of Taste and Smell, edited by Finger et al unusual brain growth patterns in early life in patients with autistic (Pritchard), 2001;57:165 disorder: an MRI study (Courchesne et al), 2001;57:245 Neurologic Catastrophes in the Emergency Department, Wijdicks Autoimmunity (Commichau), 2001;57:1745 liver and thyroid function and autoimmunity during interferon-81b Neuro-Ophthalmology: Diagnosis and Management, edited by Lin et al treatment for MS (Durelli et al), 2001;57:1363 (Lavin), 2001;57:748 Autosomal dominant inheritance Palliative Care in Amyotrophic Lateral Sclerosis, edited by Oliver et al autosomal dominant disorder with episodic ataxia, vertigo, and (Goldblatt), 2001;57:165 tinnitus (Steckley et al), 2001;57:1499 new autosomal dominant pure cerebellar ataxia (Storey et al), 2001 Pediatric Epilepsy: Diagnosis and Therapy, 2nd ed., edited by Pellock et al (Novotny Jr), 2001;57:165 1913 novel autosomal dominant spinocerebellar ataxia (SCA16) linked te Vascular Dementia, edited by Meyer et al (Lopez), 2001;57:1745 chromosome 8q22.1—24.1 (Miyoshi et al), 2001;57:96 Botulinum toxin novel missense adenine nucleotide translocator-1 gene mutation in a botulinum toxin type a in primary palmar hyperhidrosis: randomized, Greek adPEO family (Napoli et al), 2001;57:2295 single-blind, two-dose study (Saadia et al), 2001;57:2095 Autosomal recessive inheritance historical aspects of botulinum toxin (Devriese and Devriese) (Letter), adult-onset autosomal recessive ataxia with thalamic lesions in a 2001;57:1144 Finnish family (Rantamaki et al), 2001;57:1043 Bowel function somatic and germline mosaic mutation in MPZ/P, mimics recessi frequency of bowel movements and the future risk of Parkinson’s inheritance of CMT1B (Fabrizi et al), 2001;57:101 disease (Abbott et al), 2001;57:456 Axons Brain. See also specific areas of brain axonal loss in normal-appearing white matter in a patient with acut anomalous anatomy of speech-language areas in adults with persistent MS (Bjartmar et al), 2001;57:1248 developmental stuttering (Foundas et al), 2001;57:207 satellite potentials on EMG: neurophysiolos ic evidence of axonal brain proton magnetic resonance spectroscopy in children exposed to transection in MS? (Antonini et al), 2001;57:1126 methamphetamine in utero (Smith et al), 2001;57:255 chromosome 22q and the mind-brain interface: bedside to bench to B bedside (Perey and Nemeroff) (Editorial), 2001;57:377 do stutterers have different brains? (Rosenfield) (Editorial), 2001;57: Beta blockade 171 asystole induced by edrophonium followings beta blockade (Okun et effects of estrogen replacement therapy on human brain aging: an in 2001;57:739 vivo 'H MRS study (Robertson et al), 2001;57:2114 Biological markers face module, face network: the cognitive architecture of the brain cholesterol and neuropathological markers of AD: a population-based revealed through studies of face processing (Chatterjee and Farah) autopsy study (Launer et al), 2001;57:1447 (Editorial), 2001;57:1151 clinical markers of early disease in persons near onset of Huntington’s HIV in the brain: RNA levels and patterns of zidovudine resistance disease (Paulsen et al), 2001;57:658 (McClernon et al), 2001;57:1396 fatigue is not associated with raised inflammatory markers in multipl human brain imaging in the upright position (Nakada and Tasaka), sclerosis (Giovannoni et al), 2001;57:676 2001;57:1720 optimizing the association between disability and biological markers in mannitol bolus preferentially shrinks non-infarcted brain in patients MS (Kalkers et al), 2001;57:1253 with ischemic stroke (Videen et al), 2001;57:2120 Blood HO-1 mRNA postmortem brain abnormalities or the glutamate neurotransmitter blood HO-1 mRNA in AD and MCI (Schipper et al), 2001;57:2142 system in autism (Purcell et al), 2001;57:1618 Blood pressure unusual brain growth patterns in early life in patients with autistic hypotension and cognitive impairment: selective association in patients disorder: an MRI study (Courchesne et al), 2001;57:245 with heart failure (Zuccala et al), 2001;57:1986 Brain atrophy lowering blood pressure in acute intracerebral hemorrhage: safe, but apolipoprotein E e4 and the pattern of regional brain atrophy in will it help? (Morgenstern and Yonas) (Editorial), 2001;57:5 Alzheimer’s disease (Hashimoto et al), 2001;57:1461 Blood vessels. See also Vascular disorders; specific vessels craniovascular selectivity of eletriptan and sumatriptan in human effects of IV methylprednisolone on brain atrophy in relapsing- isolated blood vessels (Humphrey et al) (Letter); (Saxena et al remitting MS (Zivadinov et al), 2001;57:1239 increased nitric oxide products in CSF in primary progressive MS may (Reply), 2001;57:162 inhibition of thrombus formation by low-dose acetylsalicylic acid, reflect brain atrophy (Peltola et al), 2001;57:895 dipyridamole, and their combination in a model of platelet-vessel intention tremor, parkinsonism, and generalized brain atrophy in male wall interaction (Miller) (Sept, supp! 2), 2001;57:S8 carriers of fragile X (Hagerman et al), 2001;57:127 vascular biology of thrombosis: platelet-vessel wall interactions and rates of global and regional cerebral atrophy in AD and frontotemporal aspirin effects (Catella-Lawson) (Sept, suppl 2), 2001;57:S5 dementia (Chan et al), 2001;57:1756 vascular biology of thrombosis: the role of platelet-vessel wall adhesion Brain infarction (Fitzgerald), (Sept, supp! 2), 2001;57:S1 hypercholesterolemia, lipid-lowering agents, and the risk for brain Body weight infarction (Amarenco) (Sept, suppl 2), 2001;57:S35 weight change associated with valproate and lamotrigine monotherapy Brain injury in patients with epilepsy (Luefe t al) (Letter); (Biton) (Reply), 2001; early-life seizures in rats increase susceptibility to seizure-induced 57:565 brain injury in adulthood (Koh et al) (Dec, suppl 4), 2001;57:S22 Bone Brain localization decreased bone mass and increased bone turnover with valproate localization of the “sneeze center” (Suranyi) (Letter); (Fink) (Reply), therapy in adults with epilepsy (Sato et al), 2001;57:445 2001;57:161 Book reviews Brain metabolites Advances in Neurology, Vol. 83: Functional Imaging in the Epilepsies brain metabolite concentration and dementia severity in Alzheimer’s edited by Henry et al (Collins), 2001;57:372 disease: a 'H MRS study (Huang et al), 2001;57:626 December (2 of 2) 2001 NEUROLOGY 57 2329 Brand-name drugs Catecholamines buy some today: can generics be safely substituted for brand-name catecholamines in patients with 22q11.2 deletion syndrome and the drugs? (Lesser and Krauss) (Editorial), 2001;57:569 low-activity COMT polymorphism (Graf et al), 2001;57:410 Brown-Séquard, C. E. Catechol-O-methyltransferase Brown-Séquard and S. Weir Mitchell letters (Goetz and Aminoff), catecholamines in patients with 22q11.2 deletion syndrome and the 2001;57:2100 low-activity COMT polymorphism (Graf et al), 2001;57:410 Bulbar palsy Caveolin-3 gene delayed post-irradiation bulbar palsy in nasopharyngeal carcinoma sporadic case of rippling muscle disease caused by a de novo caveolin-3 (Chew et al), 2001;57:529 mutation (Vorgerd et al), 2001,57:2273 Bupropion CD4* cells double-blind, randomized trial of bupropion SR for the treatment of TNFa production by CD4° T cells predicts long-term increase in lesion neuropathic pain (Semenchuk et al), 2001;57:1583 load on MRI in MS (Killestein et al), 2001;57:1129 Cerebellar ataxia. See also Spinocerebellar ataxia cerebellar ataxia associated with heteroallelic ceruloplasmin gene Cc mutation (Miyajima et al), 2001;57:2205 CADASIL new autosomal dominant pure cerebellar ataxia (Storey et al), 2001;57: acetazolamide for the treatment of migraine with aura in CADASIL 1913 (Forteza et al), 2001;57:2144 Cerebellum cerebral microbleeds in CADASIL (Lesnik Oberstein et al), 2001;57: cerebellar lesions impair rapid saccade amplitude adaptation (Straube 1066 et al), 2001;57:2105 mitochondrial dysfunction associated with a mutation in the Notch3 cerebellar mediation of the complexity of bimanual compared to gene in a CADASIL family (de la Pena et al), 2001;57:1235 unimanual movements (Tracy et al), 2001;57:1862 NOTCHS3 mutation involving three cysteine residues in a family with resolution of intractable hiccups caused by cerebellar typical CADASIL (Dichgans et al), 2001;57:1714 hemangioblastoma (Seyama et al), 2001;57:2142 CAG repeat Cerebral aneurysms striatal volume loss in HD as measured by MRI and the influence small cerebral aneurysms presenting with symptoms other than CAG repeat (Rosas et al), 2001;57:1025 rupture (Friedman et al), 2001;57:1212 Callosotomy Cerebral arteries MRI assessment of spared fibers following callosotomy: a second look carotid dissection with and without ischemic events: local symptoms (Corballis et al), 2001;57:1345 and cerebral artery findings (Baumgartner et al), 2001;57:827 Canalolothiasis Cerebral atrophy continuous vertigo and spontaneous nystagmus due to canalolithiasis rates of global and regional cerebral atrophy in AD and frontotemporal of the horizontal canal (Leigh) (Letter); (von Brevern et al) (Reply), dementia (Chan et al), 2001;57:1756 2001;57:745 Cerebral blood flow Cancer therapy autoregulation of cerebral blood flow surrounding acute (6 to 22 hours) adverse long-term effects of brain radiotherapy in adult low-grade intracerebral hemorrhage (Powers et al), 2001;57:18 glioma patients (Lunsford and Kondziolka) (Letter); (Surma-aho) Cerebral cavernous malformations (Reply); (DeAngelis) (Reply), 2001;57:2150 prospective follow-up of 33 asymptomatic patients with familial delayed post-irradiation bulber palsy in nasopharyngeal carcinoma cerebral cavernous malformations (Labauge et al), 2001;57:1825 (Chew et al), 2001;57:529 Cerebral microbleeds response to cancer therapy in a patient with a paraneoplastic cerebral microbleeds in CADASIL (Lesnik Oberstein et al), 2001;57: choreiform disorder (Croteau et al), 2001;57:719 1066 Cannabinoids Cerebral sinus thrombosis cannabinoids reduce levodopa-induced dyskinesia in Parkinson’s cerebral sinus thrombosis with tamoxifen (Meyer) (Letter); (Finelli and disease: a pilot study (Sieradzan et al), 2001;57:2108 Schauer) (Reply), 2001;57:2150 Caput medusae Cerebrospinal fluid caput medusae after sinus venous thrombosis (Meyer and Hoffman) cerebrospinal fluid production rate is reduced in dementia of the (Neuro/mages), 2001;57:1376 Alzheimer’s type (Silverberg et al), 2001;57:1763 Carbamazepine CSF antiretroviral drug penetrance and the treatment of HIV- early hormonal! changes during valproate or carbamazepine treatment: associated psychomotor slowing (Sacktor et al), 2001;57:542 a 3-month study (Rattya et al), 2001;57:440 diagnosis of HAM/TSP based on CSF proviral HTLV-I antibody index is carbamazepine teratogenic? a prospective controlled study of 210 (Puccioni-Sohler), 2001;57:725 pregnancies (Diav-Citrin et al), 2001;57:321 dilated cervical epidural veins and extra arachnoid fluid collection in sudden withdrawal of carbamazepine increases cardiac sympathetic orthostatic headaches (Férderreuther et al), 2001;57:527 activity in sleep (Hennessy et al), 2001;57:1650 efficacy of epidural blood patch in spontaneous CSF leaks (Sencakova Carbon monoxide et al), 2001;57:1921 carbon monoxide-mediated hippocampal injury (Gottfried and Chatterjee) (Neuro/mages), 2001;57:17 14-3-3 protein in the CSF as a prognostic marker in early multiple Cardiac thrombus sclerosis (Martinez-Yélamos et al), 2001;57:722 thrombolytic therapy in acute ischemic stroke patients with cardiac increased CSF cortisol in AD is a function of APOE genotype (Sass et thrombus (Derex et al), 2001;57:2122 al) (Letter); (Wilkinson and Peskind) (Reply), 2001;57:1522 Cardiomyopathy increased glutamate in CSF and plasma of patients with HIV homozygosity (E140K) in SCO2 causes delayed infantile onset of dementia (Ferrarese et al), 2001;57:671 cardiomyopathy and neuropathy (Jaksch et al), 2001;57:1440 increased nitric oxide products in CSF in primary progressive MS may Carotenoids reflect brain atrophy (Peltola et al), 2001;57:895 intakes of carotenoids, vitamin C, and vitamin E and MS risk among levels of nerve growth factor in cerebrospinal fluid of chronic daily two large cohorts of women (Zhang et al), 2001;57:75 headache patients (Sarchielli et al), 2001;57:132 Carotid artery Cerebrospinal fluid filtration carotid dissection with and without ischemic events: local symptoms CSF filtration is an effective treatment of Guillain-Barré syndrome: a and cerebral artery findings (Baumgartner et al), 2001;57:827 randomized clinical trial (Wollinsky et al), 2001;57:774 high-grade carotid stenosis detected before general surgery: is drain the roots: a new treatment for Guillain-Barré syndrome? (Feasby endarterectomy indicated? (Evans and Wijdicks), 2001;57:1328 and Hartung) (Editorial), 2001;57:753 recurrent ischemia in symptomatic carotid occlusion: prognostic value Cerebrotendinous xanthomatosis of hemodynamic factors (Dobkin) (Letter); (Klijn et al) (Reply), cerebrotendinous xanthomatosis (Federico and Dotti) (Letter); (Fleck) 2001;57:161 (Reply), 2001;57:1744 Carotid endarterectomy Cerebrum clinical carotid endarterectomy decision-making: noninvasive vascular prospective study of cerebral white matter abnormalities in older imaging versus angiography (Young and Humphrey) (Letter); people with gait dysfunction (Whitman et al), 2001;57:990 (Johnston and Goldstein) (Reply), 2001;57:2324 Certification high-grade carotid stenosis detected before general surgery: is frecertification for neurologists (directors for neurology, American endarterectomy indicated? (Evans and Wijdicks), 2001;57:1328 Board of Psychiatry and Neurology), 2001;57:175 Carotid stenting Ceruloplasmin gene hyperperfusion-induced intracerebral hemorrhage after carotid cerebellar ataxia associated with heteroallelic ceruloplasmin gene stenting documented by TCD (Pfefferkorn et al), 2001;57:1933 mutation (Miyajima et al), 2001;57:2205 Cataracts Cervical artery dissections mutation in mt tRNALeu'““™ causing a neuropsychiatric syndrome pathogenesis of cervical artery dissections: association with connective with depression and cataract (Jaksch et al), 2001;57:1930 tissue abnormalities (Brandt et al), 2001;57:24 2330 NEUROLOGY 57 December (2 of 2) 2001 Cervical dystonia cognitive deficits in children with gelastic seizures and hypothalamic bilateral pallidal deep brain stimulation for cervical and truncal hamartoma (Frattali et al), 2001;57:43 cognitive deficits in patients with essential tremor (Lombardi et al), Cervical epidural veins 2001;57:785 dilated cervical epidural veins and extra arachnoid fluid collection cognitive impairment in congestive heart failure? embolism vs orthostatic headaches (Férderreuther et al), 2001;57:527 hypoperfusion (Pullicino and Hart) (Editorial), 2001;57:1945 Chanukah cognitive impairment in sporadic ALS: a pathologic continuum miracle of Chanukah (Login), 2001;57:2146 underlying a multisystem disorder (Wilson et al), 2001;57:651 Charcot-Marie-Tooth disease decrease of N-acetylaspartate in the MTL correlates with cognitive somatic and germline mosaic mutation in MPZ/P, mimics recessive decline of AD patients (Jessen et al), 2001;57:930 inheritance of CMT1B (Fabrizi et al), 2001;57:101 enhancing analogic reasoning with rT™MS over the left prefrontal Chemokine receptors cortex (Boylan) (Letter); (Boroojerdi et al) (Reply), 2001;57:1349 distinct chemokine receptor and cytokine expression profile in evidence for cortical “disconnection” as a mechanism of age-related secondary progressive MS (Sorensen id Sellebjerg), 2001;57:1371 cognitive decline (O’Sullivan et al), 2001;57:632 Chickenpox face module, face network: the cognitive architecture of the brain serial MR angiography and contrast-enhanced MRI in chickenpox revealed through studies of face processing (Chatterjee and Farah) associated stroke (Gilbert) (Letter), 2001;57:1742 (Editorial), 2001;57:1151 Children. See Pediatric patients gender difference in the association between APOE genotype and age- Chlamydia pneumoniae related cognitive deciine (Mortensen and Hogh), 2001;57:89 failure to detect Chlamydia pneumoniae in the central nervous head size and cognitive ability in nondemented older adults are related of patients with MS (Numazaki and Chibar) (Letter); (Boman et (Steiner and Newman) (Letter); (Tisserand et al) (Reply), 2001;57: (Reply), 2001;57:746 2149 Cholesterol high-dose estradiol improves cognition for women with AD: results of a cholesterol and Alzheimer’s disease: is there a link? (Simons et al randomized study (Asthana et al), 2001;57:605 2001;57:1089 hormone replacement therapy and reduced cognitive decline in older cholesterol and neuropathological markers of AD: a population-based women (Carlson et al), 2001;57:2210 autopsy study (Launer et al), 2001;57:1447 hypotention and cognitive impairment: selective association in patients Chorea with heart failure (Zuccala et al), 2001;57:1986 hereditary benign chorea: clinical and genetic features of a distinct mapping callosal morphology and cognitive correlates: effects of heavy disease (Fernandez et al), 2001;57:106 prenatal alcohol exposure (Sowell et al), 2001;57:235 Choreiform disorders memory complaints and APOE-e4 accelerate cognitive decline in response to cancer therapy in a patient with a paraneoplastic cognitively normal elderly (Dik et al), 2001;57:2217 choreiform disorder (Croteau et al), 2001;57:719 MRI predictors of cognition in subcortical ischemic vascular disease Choroidal cells and Alzheimer’s disease (Mungas et al), 2001;57:2229 mitochondrial enzyme-deficient hippocampal! neurons and choroida poststroke dementia: incidence and relationship to prestroke cognitive cells in AD (Cottrell et al), 2001;57:260 decline (Hénon et al), 2001;57:1216 Chromosome 17 prevalence of cognitive impairment: data from the Indianapolis Study clinical characteristics of a family with chromosome 17-linked of Health and Aging (Unverzagt et al), 2001;57:1655 disinhibition-dementia-parkinsonism-amyotrophy complex (Lynch progression of impairment in patients with vascular cognitive et al) (Nov, suppl 3), 2001;57:S39 impairment without dementia (Wentzel et al), 2001;57:714 Chromosome 20 13-year-old boy with cognitive impairment, retinoblastoma, and Wilson ring chromosome 20 epilepsy Sy ndrome in children: electroclinical disease (Riley et al), 2001;57:141 features (Augustijn et al), 2001;57:1108 Cognitive tests Chromosome 22q cognitive tests that best discriminate between presymptomatic AD and chromosome 22q and the mind-brain interface: those who remain nondemented (Tierney) (Letter); (Chen et al) bedside (Percy and Nemeroff) (Editorial), 2001;57:377 (Reply), 2001;57:163 Chromosome 22q11.2 Joma catecholamines in patients with 22q11.2 deletion syndrome and ths diffusion-weighted MR in hypoglycemic coma (Finelli), 2001;57:933 low-activity COMT polymorphism (Graf et al), 2001;57:410 somplex regional pain syndrome Cingulate gyrus are the complex regional pain syndromes due to neurogenic hyperperfusion of anterior cingulate gyrus in a case of paroxysmal inflammation? (Bennett) (Editorial), 2001;57:2161 nocturnal dystonia (Schindler et al), 2001;57:917 important role of neuropeptides in complex regional pain syndrome Citicoline (Birklein et al), 2001;57:2179 phase III randomized efficacy trial of 2000 mg citicoline in acute pain increases during sympathetic arousal in patients with complex ischemic stroke patients (Clark et al), 2001;57:1595 regional pain syndrome (Drummond et al), 2001;57:1296 Citrullinemia Jompulsive grasping hand syndrome high serum pancreatic secretory trypsin inhibitor before onset of type compulsive grasping hand syndrome: a variant of anarchic hand II citrullinemia (Tsuboi et al), 2001;57:933 (Kumral), 2001;57:2143 Claude’s syndrome Soncussion localization of Claude’s syndrome (Seo et al), 2001;57:2304 concussion: the history of clinical and pathophysiological concepts and Clinical criteria misconceptions (McCrory and Berkovic), 2001;57:2283 accuracy of clinical criteria for AD in the Honolulu-Asia Aging Study persistent prolongation of simple reaction time in sports concussion population-based study (Petrovitch et al), 2001;57:226 (Warden et al), 2001;57:524 Clomethiazole Congestive heart failure Clomethiazole Acute Stroke Study in tissue-type plasminogen cognitive impairment in congestive heart failure? embolism vs activator-treated stroke (CLASS-T): fing il results (Lyden et al hypoperfusion (Pullicino and Hart) (Editorial), 2001;57:1945 2001;57:1199 Connective tissue Clozapine pathogenesis of cervical artery dissections: association with connective olanzapine and clozapine: comparative effects on motor function i tissue abnormalities (Brandt et al), 2001;57:24 hallucinating PD patients (Sa and Lang) (Letter); (Leucht) (1 Connexin 32 gene (Goetz) (Reply), 2001;57:747 episodes of generalized weakness in two sibs with the R164Q mutation Coagulopathies of the connexin 32 gene (Panas et al), 2001;57:1906 improving patient selection for coagulopathy testing in the setting of Copolymer 1 acute ischemic stroke (Bushnell et al), 2001;57:1333 copolymer 1 reduces relapse rate and improves disability in relapsing- Cocaine remitting multiple sclerosis: results of a phase III multicenter, cocaine-induced persistent dyskinesias (Frucht) (Letter), 2001;57:1525 double-blind, placebo-controlled trial (Johnson et al), 2001;57:S16 Coenzyme Q,o HLA-DRB1*1501 and response to copolymer-1 therapy (Fusco et al), coenzyme Q,, reverses pathological phenotype and reduces apoptosis 2001;57:1976 in familial CoQ,, deficiency (Di Giovanni et al), 2001;57:515 Copper metabolism cue to queue for CoQ? (Shults and Schapira) (Editorial), 2001;57:375 evidence for disturbances of copper metabolism in dystonia: from the randomized, placebo-controlled trial of coenzyme Q,, and remacemide image towards a new concept (Becker et al) (Dec, suppl 5), 2001;57: in Huntington’s disease (The Huntington Study Group), 2001;57 2290 397 Corpus callosum Cognitive function. See also Dementia; Memory mapping callosal morphology and cognitive correlates: effects of heavy cerebral white matter lesions and subjective cognitive dysfunction: The prenatal alcohol exposure (Sowell et al), 2001;57:235 Rotterdam Scan Study (Stewart) (Letter); (de Groot and Breteler MRI assessment of spared fibers following callosotomy: a second look (Reply), 2001;57:2149 (Corballis et al), 2001;57:1345 December (2 of 2) 2001 NEUROLOGY 57 2331 Corrections lack of an association between cystatin C gene polymorphisms in to: ADEM: distinct disease or part of the MS spectrum? (Hartung and Japanese patients with Alzheimer’s disease (Maruyama et al), Grossman), 2001;57:1146 2001;57:337 to: early development ofi ntractable epilepsy in children: a prospective Cysteine study (Berg et al), 2001;57:939 NOTCH3 mutation involving three cysteine residues in a family with to: fulminant failure during interferon beta treatment of multiple typical CADASIL (Dichgans et al), 2001;57:1714 sclerosis (Yoshida et al), 2001;57:2153 Cysticercosis to: 1-year, placebo-controlled preservation of function survival study of visual loss in cysticercosis: analysis of 23 patients (Chang and Keane), donepezil in AD patients (Mohs et al), 2001;57:1942 2001;57:545 to: prospective study of cerebral white matter abnormalities in older Cytokines. See also specific cytokines people with gait dysfunction (Whitman et al), 2001;57:1942 distinct chemokine receptor and cytokine expression profile in to: PRISMS-4: long term efficacy of interferon-8-la in relapsing MS secondary progressive MS (Sorensen and Sellebjerg), 2001;57:1371 (PRISMS Study Group and British Columbia MS/MRI Analysis do titin and cytokine antibodies in MG patients predict thymoma of Group), 2001;57:1146 thymoma recurrence? (Buckley et al), 2001;57:1579 to: safety and efficacy of pallidal or subthalamic nucleus stimulation in advanced Parkinson’s disease (Volkmann et al), 2001;57:1354 to: SOD1 gene mutation in a patient with slowly progressing ALS D (Penco et al), 2001;57:1146 D439A gene to: 24-week, randomized, double-blind study of donepezil in moderate novel presenilin 2 gene mutation (D439A) in a patient with early onset to severe Alzheimer’s disease (Feldman et al), 2001;57:2153 Alzheimer’s disease (Lle6é et al), 2001;57:1926 Cortex Danaparoid hyperexcitable cortical responses in progressive myoclonic epilepsy: a ischemic stroke outcome: racial differences in the trial of danaparoid in TMS study (Manganotti et al), 2001;57:1793 acute stroke (TOAST) (Hassaballa et al), 2001;57:691 psychosis of Alzheimer’s disease is associated with elevated muscarinic Danon disease M, binding in the cortex (Lai et al), 2001;57:805 infantile autophagic vacuolar myopathy is distinct from Danon disease Cortical activity (Yamamoto et al), 2001;57:903 bilateral movement enhances ipsilesional cortical activity in acute DCX gene stroke: a pilot functional MRI study (Cuadrado and Arias) (Letter); (Staines et al) (Reply), 2001;57:1741 incomplete penetrance with normal MRI in a woman with germline mutation of the DCX gene (Demelas et al), 2001;57:327 Cortical development classification system for malformations of cortical development: update Deep brain stimulation 2001 (Barkovich et al), 2001;57:2168 bilateral pallidal deep brain stimulation for cervical and truncal Cortical disconnection dystonia (Andaluz et al), 2001;57:557 evidence for cortical “disconnection” as a mechanism of age-related deep brain stimulation in the treatment of Parkinson’s disease: a cost cognitive decline (O’Sullivan et al), 2001;57:632 effectiveness analysis (Tomaszewski and Holloway), 2001;57:663 Cortical dysplasia failure of long-term pallidal stimulation corrected by subthalamic differential expression of glutamate and GABA-A receptor subunit stimulation in PD (Hammerstad et al) (Letter); (Houeto et al) mRNA in cortical dysplasia (Roesler et al) (Letter); (Crino) (Reply), (Reply), 2001;57:566 2001;57:2325 interactions between deep brain stimulation and levodopa in Cortical excitability Parkinson's disease (Nutt et al), 2001;57:1835 changing cortical excitability with low-frequency magnetic stimulation Delirium (Chen and Seitz) (Editorial), 2001;57:379 delirium from nicotine withdrawal in neuro-ICU patients (Mayer et sustained excitability elevations induced by transcranial DC motor al), 2001;57:551 cortex stimulation in humans (Nitsche and Paulus), 2001;57:1899 Delivery Cortical function "H-MR spectroscopy is sensitive to subtle effects of perinatal asphyxia autism in tuberous sclerosis complex is related to both cortical and (Maneru et al), 2001;57:1115 subcortical dysfunction (Asano et al), 2001;57:1269 Dementia. See a/so Alzheimer’s di ;V. lar d tia as time goes by: high temporal and spatial resolution in cognitively clinical characteristics of a family with chromosome 17-linked related cortical function (Grossman and Gotman) (Editorial), 2001; disinhibition-dementia-parkinsonism-amyotrophy complex (Lynch 57:1947 et al) (Nov, suppl 3), 2001;57:S39 Cortical localization dementia with Lewy bodies and AD are not associated with occipital cortical localization of reading in normal children: an fMRI language lobe atrophy on MRI (Middelkoop et al), 2001;57:2117 study (Gaillard et al), 2001;57:47 differing patterns of temporal atrophy in Alzheimer’s disease and Cortical malformations semantic dementia (Galton et al), 2001;57:216 seizure outcome after functional hemispherectomy for malformations of increased glutamate in CSF and plasma of patients with HIV cortical development (Carrefio et al), 2001;57:331 dementia (Ferrarese et al), 2001;57:671 Corticobasal degeneration increased prevalence of vascular dementia in Japan: a community- neural and cognitive bases of upper limb apraxia in corticobasal based epidemiological study (Ikeda et al), 2001;57:839 degeneration (Peigneux et al), 2001;57:1259 neuroanatomy of the self: evidence from patients with frontotemporal Corticospinal excitability dementia (Miller et al), 2001;57:817 effect of levetiracetam on human corticospinal excitability (Sohn et al), polka music and semantic dementia (Boeve and Geda) (Neuro/mages), 2001;57:858 2001;57:1485 Corticospinal tract poststroke dementia: incidence and relationship to prestroke cognitive evidence of activity-dependent withdrawal of corticospinal projections decline (Hénon et al), 2001;57:1216 during human development (Eyre et al), 2001;57:1543 practice parameter: management of dementia (an evidence based taking sides: corticospinal tract plasticity during development (Wolpaw review) (Oken) (Letter); (Doody) (Reply), 2001;57:2323 and Kaas) (Editorial), 2001;57:1530 prospective analysis of risk factors for nursing home placement of volumetric analysis reveals corticospinal tract degeneration and dementia patients (Smith et al), 2001;57:1467 extramotor involvement in ALS (Ellis et al), 2001;57:1571 rates of global and regional cerebral atrophy in AD and frontotemporal Craniofacial disorders dementia (Chan et al), 2001;57:1756 craniofacial and cutaneous findings expand the phenotype of recognition of familiar handwriting in stroke and dementia (Heckmann hereditary neuralgic amyotrophy (Jeannet et al), 2001;57:1963 et al), 2001;57:2128 Creatine monohydrate semantic dementia versus Alzheimer’s disease: a matter of semantics? creatine monohydrate does not increase strength in patients with (Morris and Balota) (Editorial), 2001;57:173 hereditary neuropathy (Doherty et al), 2001;57:559 two-octapeptide repeat deletion of prion protein associated with rapidly Creutzfeldt-Jakob disease progressive dementia (Beck et al), 2001;57:354 quantitation of 14-—3-3 and neuron-specific enolase proteins in CSF in Demyelination Creutzfeldt-Jakob disease (Aksamit Jr), 2001;57:728 bilateral sectoranopia from probable osmotic demyelination (Barton), Cupulolithiasis 2001;57:2318 localizing signs in a positional vertigo due to lateral canal Depression cupulolithiasis (Bisdorff and Debatisse), 2001;57:1085 mutation in mt tRNALeu'’® causing a neuropsychiatric syndrome Cyclooxygenase-2 with depression and cataract (Jaksch et al), 2001;57:1930 marked increase in cyclooxygenase-2 in ALS spinal cord: implications prevalence and correlates of parkinsonism in patients with primary for therapy (Yasojima et al), 2001;57:952 depression (Starkstein et al), 2001;57:553 Cystatin C gene Dexfenfluramine cystatin C polymorphism is not associated with early onset Alzheimer’s dexfenfluramine effective in drug-resistant temporal lobe epilepsy disease (Roks et al), 2001;57:366 (Grosso et al), 2001;57:1139 2332 NEUROLOGY 57 December (2 of 2) 2001 Diabetes mellitus Drugs. See also specific drugs and drug types epidermal nerve innervation in impaired glucose tolerance and buy some today: can generics be safely substituted for brand-name diabetes-associated neuropathy (Sm al), 2001;57:1701 drugs? (Lesser and Krauss (Editorial), 2001;57:569 lamotrigine reduces painful diabetic neuropathy: a randomized Dura controlled study (Eisenberg et al), 2001;57:505 natural history of an incidentally discovered spinal dural Diathermy arteriovenous fistula (Houdart et al), 2001;57:742 DBS and diathermy interaction induces s¢ re CNS damage Dysferlin (Dommerholt and Issa) (Letter); (Nutt) (Reply), 2001;57:2 genomic organization of the dysferlin gene and novel mutations in DiGeorge syndrome Miyoshi myopathy (Aoki et al), 2001;57:271 catecholamines in patients with 22q11.2 deletion syndrome inflammation in dysferlin myopathy: immunohistochemical low-activity COMT polymorphism (Graf et al), 2001;57 characterization of 13 patients (Gallardo et al), 2001;57:2136 Diphenylhydantoin Dysgeusia intravenous diphenylhydantoin in treatment of acute repetitive d] ysgeusia in epileptic patients treated with lamotrigine: report of three seizures (Wallis et al) (Dec, supp! 4), 2001;57:S49 cases (Avoni et al), 2001;57:1521 Dipyridamole Dyskinesia inhibition of thrombus formation by low-dose acetylsalicylic cannabinoids reduce levodopa-induced dyskinesia in Parkinson’s dipyridamole, and their combination in a model of plate disease: a pilot study (Sieradzan et al), 2001;57:2108 wall interaction (Miiller) (Sept, suppl 2), 2001;57:S8 cocaine-induced persistent dyskinesias (Frucht) (Letter), 2001;57:1525 near-field amplification of antithrombotic effects of dipyridaz effect of subthalamic nucleus stimulation on levodopa-induced through vessel wall cells (Eisert) (Sept, supp! 2), 2001;57 dyskinesia in Parkinson’s disease (Fraix et al) (Nov, suppl 3), 2001; Disability 57:S60 APOE genotype is a major predictor of | paroxysmal kinesigenic dyskinesia and infantile convulsions: clinical disability in MS (Becker) (Letter and linkage studies (Swoboda et al) (Dec, suppl 4), 2001;57:S42 57:2148 Dyspnea copolymer 1 reduces relapse rate and in oves disability i chronic dyspnea and hyperventilation in an awake patient with small remitting multiple sclerosis: results i phase III multicent subcortical infarcts (Johnston et al), 2001;57:2131 double-blind, placebo-controlled trial Dystonia 2001;57:S16 itypical presentation of dopa-responsive dystonia: generalized evidence-based measurement: which dis: hypotonia and proximal weakness (Kong et al), 2001;57:1121 rehabilitation? (Hobart et al), 2001;57:63 paroxysmal dystonia (tonic spasm) in multiple sclerosis (Waubant et extended use of glatiramer acetate (Copaxone) on MS relapss t al), 2001;57:2320 degree of disability (Johnson et al) (De upp! 5), 2001;57:S46 Dystroglycan models of progression in AD: predicting ty and costs selective deficiency of a-dystroglycan in Fukuyama-type congenital (Mendiondo et al) (Editorial), 2001;5 muscular dystrophy (Hayashi et al), 2001;57:115 optimizing the association between disal ind biological MS (Kalkers et al), 2001;57:1253 E Disinhibition Economics clinical characteristics of a family with iussessment of health economics in Alzheimer’s disease (AHEAD): disinhibition-dementia-parkinsonis galantamine treatment in Canada (Getsios et al), 2001;57:972 et al) (Nov, suppl 3), 2001;57:S39 issessment of health economics in Alzheimer’s disease (AHEAD) based Dodecamer repeats on need for full-time care (Caro et al), 2001;57:964 Unverricht-Lundborg disease in a five-ge inpatient costs, length of stay, and mortality for cerebrovascular instability of dodecamer repeats (Ma events in community hospitals (Reed et al), 2001;57:305 Donepezil Edrophonium 1-year, placebo-controlled preservation isystole induced by edrophonium following beta blockade (Okun et al), donepezil in AD patients (Mohs et al 2001;57:739 1-year, randomized, placebo-controlled Elderly people. See also Aging with mild to moderate AD (Winblad drop attacks in older patients secondary to an otologic cause (Ishiyama randomized placebo-controlled trial of don et al), 2001;57:1103 progressive supranuclear palsy (Lit effect of apolipoprotein E genotype on hippocampal volume loss in 24-week, randomized, double-blind stud aging healthy women (Cohen et al), 2001;57:2223 severe Alzheimer’s disease (Feldman et a head size and cognitive ability in nondemented older adults are related Dopamine (Steiner and Newman) (Letter); (Tisserand et al) (Reply), 2001;57: atypical presentation of dopa-responsive 2149 hypotonia and proximal weakness (Kong « 2001;57 memory complaints and APOE-e4 accelerate cognitive decline in differential effects of D, and D. agonists in MPTP-treated p cognitively normal elderly (Dik et al), 2001;57:2217 functional implications for Parkinson’s disease (Boyce et prevalence of cognitive impairment: data from the Indianapolis Study suppl 3), 2001;57:S27 of Health and Aging (Unverzagt et al), 2001;57:1655 dopaminergic neurotransmission and restless legs syndrome prospective study of cerebral white matter abnormalities in older association analysis (Desautels et al), 2001;57:1304 people with gait dysfunction (Whitman et al), 2001;57:990 Dopamine transporter testosterone supplementation improves spatial and verbal memory in multicenter assessment of dopamine transporter imaging Uf older men (Cherrier et al), 2001;57:80 Parkinson Study Gr¢ Electrocorticography 2001;57:S52 electrocorticographic gamma activity during word production in spoken multicenter assessment of dopamine transporter imaging with and sign language (Crone et al), 2001;57:2045 DOPASCAN/SPECT in parkinsonism (Quinn) (Letter); (Park Electrode implantation Study Group) (Reply), 2001;57:746 remission of intractable partial epilepsy following implantation of DOPASCAN intracranial electrodes (Katariwala et al), 2001;57:1505 multicenter assessment of dopamine transporter imaging wit! Electroencephalography Parkinson Study Grou} continuous EEG monitoring and midazolam infusion for refractory 2001;57:S52 nonconvulsive status epilepticus (Claassen et al), 2001;57:1036 multicenter assessment of dopamine transporter imaging wit EEG criteria predictive of complicated evolution in idiopathic rolandic DOPASCAN/SPECT in parkinsonism (Quinn) (Letter epilepsy (Massa et al), 2001;57:1071 Study Group) (Reply), 2001;57:746 localizing value of ictal EEG in focal epilepsy (Foldvary et al), 2001;57: Down syndrome 2022 specificity of the fivefold increase AD in mothers of adults serial EEG during human status epilepticus: evidence for PLED as an syndrome :S chupf et al), 2001;57:979 ictal pattern (Garzon et al), 2001;57:1175 Driving Electromyography driving restrictions and people with epilepsy (Chadwick) (Editorial satellite potentials on EMG: neurophysiologic evidence of axonal 2001;57:1749 transection in MS? (Antonini et al), 2001;57:1126 increased driving accident frequency in Danish patients with epilepsy Eletriptan (Lings), 2001;57:435 craniovascular selectivity of eletriptan and sumatriptan in human individual state driving restrictions for people with epilepsy in isolated blood vessels (Humphrey et al) (Letter); (Saxena et al) U.S. (Krauss et al), 2001;57:1780 (Reply), 2001;57:162 Drop attacks Embolism drop attacks in older patients secondary to an otologic cause cognitive impairment in congestive heart failure? embolism vs et al), 2001;57:1103 hypoperfusion (Pullicino and Hart) (Editorial), 2001;57:1945 December (2 of 2) 2001 NEUROLOGY 57 2333 prognosis after percutaneous closure of patent foramen ovale for early hormonal changes during valproate or carbamazepine treatment: paradoxical embolism (Wahl et al), 2001;57:1330 a 3-month study (Rattya et al), 2001;57:440 Emergency departments EEG criteria predictive of complicated evolution in idiopathic rolandic acute stroke care in non-urban emergency departments (Burgin et al), epilepsy (Massa et al), 2001;57:1071 2001;57:2006 future directions for epilepsy research (Jacobs et al) (Views & Emotional behavior Reviews), 2001;57:1536 impaired affective prosody in AD: relationship to aphasic deficits and gabapentin as add-on therapy in refractory partial epilepsy: a double- emotional behaviors (Testa et al), 2001;57:1474 blind, placebo-controlled, parallel-group study (The US Gabapentin Encephalitis Study Group No. 5) (Dec, suppl 4), 2001;57:S62 GluR3 antibodies: prevalence in focal epilepsy but no specificity for generalized epilepsy with febrile seizures plus: further heterogeneity Rasmussen's encephalitis (Wiend] et al), 2001;57:1511 in a large family (Lerche et al), 2001;57:1191 labeling of rat neurons by anti-GluR3 IgG from patients with GluR3 antibodies: prevalence in focal epilepsy but no specificity for Rasmussen encephalitis (Frassoni et al), 2001;57:324 Rasmussen's encephalitis (Wiendl et al), 2001;57:1511 limbic encephalitis associated with recurrent thymoma: a postmortem high-dose ethosuximide for epilepsy in Angelman syndrome: study (Fujii et al), 2001;57:344 implication of GABA, receptor subunit (Sugiura et al), 2001;57: persistent movement disorders following Japanese encephalitis 1518 (Murgod et al), 2001;57:2313 how many patients with psychogenic nonepileptic seizures also have plasmapheresis in Rasmussen's encephalitis (Andrews et al) epilepsy? (Benbadis et al), 2001;57:915 (Dec, suppl 4), 2001;57:S37 hyperexcitable cortica! responses in progressive myoclonic epilepsy: a status epilepticus due to human parvovirus B19 encephalitis in an TMS study (Manganotti et al), 2001;57:1793 immunocompetent adult (Skaff and Labiner), 2001;57:1336 increased driving accident frequency in Danish patients with epilepsy suppression of post-hypoxic and post-encephalitic myoclonus with (Lings), 2001;57:435 levetiracetam (Genton and Gelisse) (Letter): (Krauss et al) (Reply), individual state driving restrictions for people with epilepsy in the 2001;57:1144 U.S. (Krauss et al), 2001;57:1780 Encephalomyelitis juvenile Huntington’s disease presenting as progressive myoclonic acute disseminated encephalomyelitis as manifestation of primary HIV epilepsy (Gambardella et al), 2001;57:708 infection (Narciso et al), 2001;57:1493 ketotic hyperglycemia and epilepsia partialis continua (Placidi et al), Encephalopathy 2001;57:534 predictive value of serum interleukin-6 level in influenza virus- localizing value of ictal EEG in focal epilepsy (Foldvary et al), 2001;57: associated encephalopathy (Aiba et al), 2001;57:295 2022 localizing value of a-methyl-L-tryptophan PET in intractable Epidemiology epilepsy of neocortical origin (Fedi et al), 2001;57:1629 aboriginals with multiple sclerosis: HLA types and predominance of malignant rolandic-sylvian epilepsy in children: diagnosis, treatment, neuromyelitis optica (Rivera and Cabrera) (Letter); (Mirsattari and and outcomes (Otsubo et al), 2001;57:590 Power) (Reply), 2001;57:937 menstrual cycle interval and ovulation in women with localization- accuracy of clinical criteria for AD in the Honolulu-Asia Aging Study, a related epilepsy (Herzog and Friedman), 2001;57:2133 more evidence for seizure-induced neuron loss: is hippocampal sclerosis population-based study (Petrovitch et al), 2001;57:226 both cause and effect of epilepsy? (Sutula and Pitkanen) age of onset of narcolepsy in two large populations of patients in (Editorial), 2001;57:169 France and Quebec (Canada) (Dauvilliers et al), 2001;57:2029 neuropsychological assessment in children with absence epilepsy cholesterol and neuropathological markers of AD: a population-based (Ronen et al) (Letter); (Pavone et al) (Reply), 2001;57:1940 autopsy study (Launer et al), 2001;57:1447 painful auras in focal epilepsy (Nair et al), 2001;57:700 genetic epidemiology of glioma (Osborne et al) (Views & Reviews), population study of benign rolandic epilepsy: is treatment needed? 2001;57:1751 (Peters et al), 2001;57:537 genome-wide linkage disequilibrium mapping of late-onset Alzheimer’s preventing seizures from “Pocket Monsters”: the control of reflex disease in Finland (Hiltunen et al), 2001;57:1663 epilepsy (Erba) (Editorial), 2001;57:1747 high incidence and increasing prevalence of MS in Enna (Sicily), prolonged cortical silent period after transcranial magnetic stimulation southern Italy (Grimaldi et al), 2001;57:1891 in generalized epilepsy (Macdonell et al), 2001;57:706 HLA-DR13 haplotype is associated with “benign” multiple sclerosis in remission of intractable partial epilepsy following implantation of northeast Italy (Perini et al), 2001;57:158 intracranial electrodes (Katariwala et al), 2001;57:1505 incidence of Alzheimer’s disease in a rural community in India: the ring chromosome 20 epilepsy syndrome in children: electroclinical Indo-US study (Chandra et al), 2001;57:985 features (Augustijn et al), 2001;57:1108 increased driving accident frequency in Danish patients with epilepsy risk of epilepsy in offspring of affected women: association with (Lings), 2001;57:435 maternal spontaneous abortion (Schupf and Ottman), 2001;57:1642 increased prevalence of vascular dementia in Japan: a community- seizure frequency and the health-related quality ofl ife of adults with based epidemiological study (Ikeda et al), 2001;57:839 epilepsy (Leidy et al) (Dec, suppl 4), 2001;57:S69 influence of leisure activity on the incidence of Alzheimer’s disease sudden unexplained death in children with epilepsy (Donner et al), (Scarmeas et al), 2001;57:2236 2001;57:430 juvenile and adult-onset acid maltase deficiency in France: genotype- vagus nerve stimulation reduces daytime sleepiness in epilepsy phenotype correlation (Ausems et al) (Letter); (Laforét et al) patients (Malow et al), 2001;57:879 (Reply), 2001;57:1938 weight change associated with valproate and lamotrigine monotherapy lack of an association between cystatin C gene polymorphisms in in patients with epilepsy (Luef et al) (Letter); (Biton) (Reply), 2001; Japanese patients with Alzheimer’s disease (Maruyama et al), 57:565 2001;57:337 Episodic ataxia type 2 mutations parkinsonism in Ontario: increased mortality compared to controls in a loss-of-function EA2 mutations are associated with impaired large cohort study (Guttman et al), 2001;57:2278 neuromuscular transmission (Jen et al), 2001;57:1843 population study of benign rolandic epilepsy: is treatment needed? Ergotamine (Peters et al), 2001;57:537 cerebral ergotism under treatment with ergotamine and ritonavir prevalence, incidence, and mortality of PD: a door-to-door survey in (Spiegel et al), 2001;57:743 Ilan County, Taiwan (Chen et al), 2001;57:1679 Ergotism selegiline and mortality in subjects with Parkinson's disease: a cerebral ergotism under treatment with ergotamine and ritonavir longitudinal community study (Van Gerpen and Ahlskog) (Letter); (Spiegel et al), 2001;57:743 (Ben-Shlomo et al) (Letter); (Donnan et al) (Reply), 2001;57:368 Estradiol spectrum of myelopathies in HIV seropositive South African patients high-dose estradiol improves cognition for women with AD: results of a (Bhigjee et al), 2001;57:348 randomized study (Asthana et al), 2001;57:605 time trends in the incidence of parkinsonism in Olmsted County, Estrogen Minnesota (Rocca et al), 2001;57:462 effects of estrogen replacement therapy on human brain aging: an in Epidermal nerves vivo 'H MRS study (Robertson et al), 2001;57:2114 epidermal! nerve innervation in impaired glucose tolerance and estrogen, progesterone, and tic severity in women with Gilles de la diabetes-associated neuropathy (Smith et al), 2001;57:1701 Tourette syndrome (Kompoliti et al), 2001;57:1519 Epilepsy. See also Seizures; Status epilepticus; Temporal lobe Ethics epilepsy ethical considerations for neurologists in the management of chronic brain glutathione levels in patients with epilepsy measured by in vivo pain (American Academy of Neurology Ethics, Law and "H-MRS (Mueller et al), 2001;57:1422 Humanities Committee), 2001;57:2166 decreased bone mass and increased bone turnover with valproate Ethosuximide therapy in adults with epilepsy (Sato et al), 2001;57:445 high-dose ethosuximide for epilepsy in Angelman syndrome: driving restrictions and people with epilepsy (Chadwick) (Editorial), implication of GABA, receptor subunit (Sugiura et al), 2001;57: 2001;57:1749 1518 2334 NEUROLOGY 57 December (2 of 2) 2001 Evoked potentials preservation of golf skills in a case of severe left lobar frontotemporal fish oil supplementation improves visual evoked potentials in children degeneration (Venneri and Shanks), 2001;57:521 with phenylketonuria (Beblo et al), 2001;57:1488 rates of global and regional cerebral atrophy in AD and frontotemporal Extinction dementia (Chan et al), 2001;57:1756 extinction, working memory, and line bisection in spatial neglect role of the supplementary motor area in motor deficit following medial (Riestra et al), 2001;57:147 frontal lobe surgery (Krainik et al), 2001;57:871 stereotyped stepping associated with lesions in the bilateral medial frontoparietal cortices (Sato et al), 2001;57:711 F Frontotemporal degeneration Face processing preservation of golf skills in a case of severe left lobar frontotemporal covert recognition in acquired and developmental prosopagnosia degeneration (Venneri and Shanks), 2001;57:521 (Barton et al), 2001;57:1161 Frontotemporal dementia face memory impairments in patients with frontal lobe damage neuroanatomy of the self: evidence from patients with frontotemporal (Rapesak et al), 2001;57:1168 dementia (Miller et al), 2001;57:817 face module, face network: the cognitive architecture of the brain Functional magnetic resonance imaging revealed through studies of face processing (Chatterjee and Farah cortical localization of reading in normal children: an fMRI language (Editorial), 2001;57:1151 study (Gaillard et al), 2001;57:47 professor or the resident? a misidentification of two faces (Nyffeler et dissociation of regional activation in mild AD during visual encoding: a al), 2001;57:556 functional MRI study (Kato et al), 2001;57:812 Facioscapulohumeral dystrophy memory fMRI lateralizes temporal lobe epilepsy (Jokeit et al), 2001;57: randomized, double-blind, placebo-controlled trial of albuterol in 1786 facioscapulohumera! dystrophy (Kissel! et al), 2001;57:1434 Fatigue G fatigue is not associated with raised inflammatory markers in 1 sclerosis (Giovannoni et al), 2001;57:676 Gabapentin Febrile seizures ALS defeats gabapentin: reflections on another failed treatment do febrile seizures improve memory? (Baram and Shinnar) (Editori (Brigell and Taylor) (Letter); (Rowland and McDermott) (Reply), 2001;57:7 2001;57:1524 generalized epilepsy with febrile seizures plus: further heterogeneity gabapentin as add-on therapy in refractory partial epilepsy: a double- in a large family (Lerche et al), 2001;57:1191 blind, placebo-controlled, parallel-group study (The US Gabapentin hippocampal malformation as a cause of familial febrile convulsions and Study Group No. 5) (Dec, svppl 4), 2001;57:S62 subsequent hippocampal sclerosis (Fernandez et al) (Dec, suppl 4 treatment of idiopathic restless legs syndrome (RLS) with gabapentin 2001;57:S13 (Happe et al), 2001;57:1717 Na, 1.1 mutations cause febrile seizures associated with afebrile partial GAD,, antibodies seizures (Sugawara et al), 2001;57:703 stiff person syndrome: quantification, specificity, and intrathecal partial and generalized epilepsy with febrile seizures plus and a nove synthesis of GAD,, antibodies (Dalakas et al), 2001;57:780 SCNIA mutation (Abou-Khalil et al), 2001;57:2265 G664A gene prolonged febrile convulsions and mesial! temporal! lobe epilepsy in atrial natriuretic peptide gene G664A polymorphism and the risk of identical twin (Schulz and Ebner), 2001;57:318 ischemic cerebrovascular disease (Hassan et al), 2001;57:1726 working memory of school-aged children with a history of febrile Gait convulsions: a population study (Chang et al), 2001;57 effects of bilateral subthalamic nucleus stimulation on parkinsonian Fetus gait (Stolze et al), 2001;57:144 brain proton magnetic resonance spectroscopy in children exposed t prospective study of cerebral white matter abnormalities in older methamphetamine in utero (Smith et al), 2001;57:255 people with gait dysfunction (Whitman et al), 2001;57:990 is carbamazepine teratogenic? a prospective controlled study of 2i( Gamma-aminobutyric acid receptors pregnancies (Diav-Citrin et al), 2001;57:321 differential expression of glutamate and GABA-A receptor subunit mapping callosal morphology and cognitive correlates: effects of hea mRNA in cortical dysplasia (Roesler et al) (Letter); (Crino) (Reply), prenatal alcohol exposure (Sowell et al), 2001;57:235 2001;57:2325 risk of epilepsy in offspring of affected women: association with high-dose ethosuximide for epilepsy in Angelman syndrome: maternal spontaneous abortion (Schupf and Ottman), 2001;57 implication of GABA, receptor subunit (Sugiura et al), 2001;57:1518 Fever. See also Febrile seizures Gastrostomy tubes intractable fever and cortical neuronal glycogen storage in glyc noninvasive ventilation allows gastrostomy tube placement in patients type 2 (Martini et al), 2001;57:906 with advanced ALS (Rowin and Meriggioli) (Letter); (Rio and prophylactic antipyretic treatment with acetaminophen in acute Leigh) (Letter); (Boitano et al) (Reply), 2001;57:1351 ischemic stroke: a pilot study (Koennecke and Leistner), 2001;57:2 Gender. See Men; Sex; Women Fibromyalgia Generic drugs fibromyalgia is common in patients with transformed migraine (Pers buy some today: can generics be safely substituted for brand-name et al), 2001;57:1326 drugs? (Lesser and Krauss)Editorial), 2001;57:569 Fish oil Genetics. See also specific genes fish oil supplementation improves visual! evoked potentials in children \BCD1 translation-initiator mutation demonstrates genotype- with phenylketonuria (Beblo et al), 2001;57:1488 phenotype correlation for AMN (O'Neill et al), 2001;57:1956 FLAIR ANT 1, Twinkle, POLG, TP: new genes open our eyes to fluid-attenuated inversion recovery: correlations of hippocampal cell ophthalmoplegia (Hirano and DiMauro) (Editorial), C3 association densities with signal abnormalities (Diehl! et al), 2001;57:1029 of a tumor necrosis factor a polymorphism with MS susceptibility Folate (Weinshenker et al), 2001;57:1341 catecholamines in patients with vitamin B,, and folate in relation to the development of Alzheimer’s 22q11.2 deletion syndrome and the low-activity COMT disease (Rieder and Fricke) (Letter); (Wang et al) (Reply), 2001;57 polymorphism (Graf et al), 2001;57:410 1743 cerebellar ataxia associated with heteroallelic ceruloplasmin gene 14-3-3 protein mutation (Miyajima et al), 2001;57:2205 14-3-3 protein in the CSF as a prognostic marker in early multiple chromosome 22q and the mind-brain interface: bedside to bench to sclerosis (Martinez-Yélamos et al), 2001;57:722 bedside (Percy and Nemeroff) (Editorial), 2001;57:377 quantitation of 14—3-3 and neuron-specific enolase proteins in CSF clinical characteristics of a family with chromosome 17-linked Creutzfeldt-Jakob disease (Aksamit Jr), 2001;57:728 disinhibition-dementia-parkinsonism-amyotrophy complex (Lynch Fragile X et al) (Nov, suppl 3), 2001;57:S39 intention tremor, parkinsonism, and generalized brain atrophy in 1 clinical implications of the genetics of ALS and other motor neuron carriers of fragile X (Hagerman et al), 2001;57:127 diseases (Orrell and Figlewicz) (Views & Reviews), 2601;57:9 Friedrich’s ataxia congenital muscular dystrophy with primary partial laminin a2 chain serum transferrin receptor levels in Friedreich’s and other deficiency: molecular study (He et al), 2001;57:1319 cystatin C degenerative ataxias (Scarano et al), 2001;57:159 polymorphism is not associated with early onset Alzheimer’s Frontal Assessment Battery disease (Roks et al), 2001;57:366 FAB: a frontal assessment battery at bedside (Royall) (Letter), 2001 DNA microarray gene expression analysis technology and its 57:565 application to neurological disorders (Greenberg) (Views & Frontal lobes Reviews), 2001;57:755 face memory impairments in patients with frontal lobe damage dopaminergic neurotransmission and restless legs syndrome: a genetic (Rapesak et al), 2001;57:1168 association analysis (Desautels et al), 2001;57:1304 oral tendency due to frontal lobe lesion (Takahashi and Kawamura episodes of generalized weakness in two sibs with the R164Q mutation 2001;57:739 of the connexin 32 gene (Panas et al), 2001;57:1906 December (2 of 2) 2001 NEUROLOGY 57 2335 essential tremor in twins: an assessment of genetic vs environmental Gliomas determinants of etiology (Tanner et al), 2001;57:1389 adverse long-term effects of brain radiotherapy in adult low-grade evidence for familial aggregation of tremor in normal individuals glioma patients (Lunsford and Kondziolka) (Letter); (Surma-aho) (Louis et al), 2001;57:110 (Reply); (DeAngelis) (Reply), 2001;57:2150 generalized epilepsy with febrile seizures plus: further heterogeneity genetic epidemiology of glioma (Osborne et al) (Views & Reviews), in a large family (Lerche et al), 2001;57:1191 2001;57:1751 genetic association studies: genes in search of diseases (Bird et al), gliomas arising in organ transplant recipients: an unrecognized 2001;57:1153 complication of transplantation? (Schiff et al), 2001;57:1486 genetic epidemiology of glioma (Osborne et al) (Views & Reviews), high frequency of the H63D mutation of the hemochromatosis gene 2001;57:1751 (HFE) in malignant gliomas (Martinez de Montemuros et al), 2001; genome-wide scan for Parkinson's disease: the GenePD Study 57,1342 (DeStefano et al), 2001;57:1124 Gliomatosis cerebri high frequency of the H63D mutation of the hemochromatosis gene possible efficacy of temozolomide in a patient with gliomatosis cerebri (HFE) in malignant gliomas (Martinez de Montemuros et al), 2001; (Benjelloun et al), 2001;57:1932 57:1342 Globus pallidus immune reactivity in a mouse model of familial ALS correlates with bilateral pallidal deep brain stimulation for cervical and truncal disease progression (Alexianu et al), 2001;57:1282 dystonia (Andaluz et al), 2001;57:557 incomplete penetrance with normal MRI in a woman with germline failure of long-term pallidal stimulation corrected by subthalamic mutation of the DCX gene (Demelas et al), 2001;57:327 stimulation in PD (Hammerstad et al) (Letter); (Houeto et al) inherited prion disease caused by the V210I mutation: transmission to (Reply), 2001;57:566 transgenic mice (Mastrianni et al), 2001;57:2198 Glucose metabolism intention tremor, parkinsonism, and generalized brain atrophy in male in vivo hippocampal glucose metabolism in mesial temporal lobe carriers of fragile X (Hagerman et al), 2001;57:127 epilepsy (Knowlton et al), 2001;57:1184 juvenile and adult-onset acid maltase deficiency in France: genotype- Glucose tolerance phenotype correlation (Ausems et al) (Letter); (Laforét et al) epidermal nerve innervation in impaired glucose tolerance and (Reply), 2001;57:1938 diabetes-associated neuropathy (Smith et al), 2001;57:1701 lack of association between ubiquitin carboxy-terminal hydrolase L1 GluR3 antibodies gene polymorphism and PD (Savetti et al), 2001;57:560 GluR3 antibodies: prevalence in focal epilepsy but no specificity for Rasmussen's encephalitis (Wiend] et al), 2001;57:1511 limb girdle and facial weakness in female carriers of X-linked Glutamate myotubular myopathy mutations (Sutton et al), 2001;57:900 differential expression of glutamate and GABA-A receptor subunit linkage of HLA to myasthenia gravis and genetic heterogeneity mRNA in cortical dysplasia (Roesler et al) (Letter); (Crino) (Reply), depending on anti-titin antibodies (Giraud et al), 2001;57:1555 2001;57:2325 LIS1 missense mutations cause milder lissencephaly phenotypes increased glutamate in CSF and plasma of patients with HIV including a child with normal IQ (Leventer et al), 2001;57:416 dementia (Ferrarese et al), 2001;57:671 mitochondrial! dysfunction associated with a mutation in the Notch3 labeling of rat neurons by anti-GluR3 IgG from patients with gene in a CADASIL family (de la Pefia et al), 2001;57:1235 Rasmussen encephalitis (Frassoni et al), 2001;57:324 mutation in mt tRNALeu'““® causing a neuropsychiatric syndrome postmortem brain abnormalities or the glutamate neurotransmitter with depression and cataract (Jaksch et al), 2001;57:1930 system in autism (Purcell et al), 2001;57:1618 Na, 1.1 mutations cause febrile seizures associated with afebrile partial Glutamine seizures (Sugawara et al), 2001;57:703 assessment of health economics in Alzheimer’s disease (AHEAD): new autosomal! dominant pure cerebellar ataxia (Storey et al), 2001;57: galantamine treatment in Canada (Getsios et al), 2001;57:972 1913 Glutathione NOTCHS3 mutation involving three cysteine residues in a family with brain glutathione levels in patients with epilepsy measured by in vivo typical CADASIL (Dichgans et al), 2001;57:1714 "H-MRS (Mueller et al), 2001;57:1422 novel autosomal! dominant spinocerebellar ataxia (SCA16) linked to Glycogenosis chromosome 8q22.1—24.1 (Miyoshi et al), 2001;57:96 intractable fever and cortical neuronal glycogen storage in glycogenosis parkin gene is not involved in late-onset Parkinson's disease (Oliveri type 2 (Martini et al), 2001;57:906 et al), 2001;57:359 Glycogen storage partial and generalized epilepsy with febrile seizures plus and a novel intractable fever and cortical neuronal glycogen storage in glycogenosis SCNIA mutation (Abou-Khalil et al), 2001;57:2265 type 2 (Martini et al), 2001;57:906 pathogenic effect of an intermediate-size spinocerebellar ataxia type 6 Glycoprotein IIb-IIla allele (CAG),, in a homozygous patient (Mariotti et al), 2001;57: from bench to bedside: GP ilb-IIla inhibitors (Fintel) (Sept, suppl 2), 1502 2001;57:S12 patterns of disease in concordant parent-child pairs with multiple platelet glycoprotein [Ib-IIla antagonists for acute ischemic stroke sclerosis (Hupperts et al), 2001;57:290 (Bogousslavsky and Leclerc) (Sept, suppl 2), 2001;57:S53 pheno/genotypic correlations of neuronal ceroid lipofuscinoses Granulomas (Wisniewski et al) (Views & Reviews), 2001;57:576 rate of spontaneous resolution of a solitary cysticercus granuloma in polymorphisms in hypocretin/orexin pathway genes and narcolepsy patients with seizures (Rajshekhar), 2001;57:2315 (Olafsdottir et al), 2001;57:1896 Growth polymorphisms in the vicinity of the hypocretin/orexin are not head growth and neurodevelopment of infants born to HIV-1-infected associated with human narcolepsy (Hungs et al), 2001;57:1893 drug-using women (Macmillan et al), 2001;57:1402 prion codon 129 homozygosity and sporadic inclusion body myositis Guillain-Barré syndrome (Lampe et ai) (Letter); (Orth et al) (Reply), 2001;57:368 anti-Gal-C antibodies in GBS subsequent to mycoplasma infection: prolonged febrile convulsions and mesial temporal lobe epilepsy in an evidence of molecular mimicry (Kusunoki et al), 2001;57:736 identical twin (Schulz and Ebner), 2001;57:318 CSF filtration is an effective treatment of Guillain-Barré syndrome: a pseudo-dominant inheritance and exon 2 triplication in a family with randomizeé clinical trial (Wollinsky et al), 2001;57:774 parkin gene mutation (Licking et al), 2001;57:924 drain the roots: a new treatment for Guillain-Barré syndrome? (Feasby recurrent subarachnoid hemorrhage associated with a new and Hartung) (Editorial), 2001;57:753 transthyretin variant (Gly53Glu) (Ellie et al), 2001;57:135 IFN-8 decreases adhesion and transmigration capacities of risk of epilepsy in offspring of affected women: association with lymphocytes in Guillain-Barré syndrome (Créange et al), 2001;57: maternal spontaneous abortion (Schupf and Ottman), 2001;57:1642 1704 SCA8 repeat expansions in ataxia: a controversial association (Sobrido et al), 2001;57:1310 sodium channel gene mutations in hypokalemic periodic paralysis: an H uncommon cause in the UK (Davies et al), 2001;57:1323 Haemophilus influenzae infection somatic and germline mosaic mutation in MPZ/P,, mimics recessive Miller Fisher syndrome and Haemophilus influenzae infection (Koga et inheritance of CMT1B (Fabrizi et al), 2001;57:101 al), 2001;57:686 specificity of the fivefold increase AD in mothers of adults with Down Hallucinations syndrome (Schupf et al), 2001;57:979 hallucinations, REM sleep, and Parkinson's disease: a medical sporadic case of rippling muscle disease caused by a de novo caveolin-3 hypothesis (Manni and Mazzarello) (Letter); (Arnulf et al) (Reply), mutation (Vorgerd et al), 2001;57:2273 2001;57:1350 Glatiramer acetate olanzapine and clozapine: comparative effects on motor function in extended use of glatiramer acetate (Copaxone) on MS relapse rate and hallucinating PD patients (Sa and Lang) (Letter); (Leucht) (Letter); degree of disability (Johnson et al) (Dec, supp! 5), 2001;57:S46 (Goetz) (Reply), 2001;57:747 glatiramer acetate reduces the proportion of new MS lesions evolving prospective longitudinal assessment of hallucinations in Parkinson’s into “black holes” (Filippi et al), 2001;57:731 disease (Goetz et al), 2001;57:2078 2336 NEUROLOGY 57 December (2 of 2) 2001

See more

The list of books you might like

Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.